Sowing of paddy crop up 37% so far in Kharif season

The sowing area has been reported mainly from West Bengal (11.25 lakh hectare), Telangana (7.45 lakh hectare), Odisha (3.13 lakh hectare), Assam (2.73 lakh hectare), Karnataka (1.64 lakh hectare), Chhattisgarh (1.50 lakh hectare), Tamil Nadu (1.44 lakh hectare) and Bihar (1.22 lakh hectare).

PTI

April 17, 2020 / 21:56 IST

Farmers have sown paddy in 32.73 lakh hectare area so far during the current Kharif (summer) season, up 37 percent from the same period last year, as the government has allowed farm activities during the lockdown period.

"About 32.73 lakh hectare area coverage under summer rice has been reported compared to 23.85 lakh hectare during the corresponding period of last year," an official statement said.

The sowing area has been reported mainly from West Bengal (11.25 lakh hectare), Telangana (7.45 lakh hectare), Odisha (3.13 lakh hectare), Assam (2.73 lakh hectare), Karnataka (1.64 lakh hectare), Chhattisgarh (1.50 lakh hectare), Tamil Nadu (1.44 lakh hectare) and Bihar (1.22 lakh hectare).

Sowing area of pulses also rose to 4.67 lakh hectare area compared to 3.55 lakh hectare during the same period of last year.

Tamil Nadu reported sowing of 1.46 lakh hectare, while Uttar Pradesh 1.28 lakh hectare.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show